D

Divi's Laboratories
DIVISLAB

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
₹1.81T
EV
₹1.77T
Shares Outstanding
265.47M
Beta
0.33

Wall Street View

Analyst Rating
HOLD
Analyst Target Price
₹6345.86
P/E 2026E
67.13x
P/Revenue 2026E
16.49x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Divi's Laboratories Limited

gainify

D

Divi's Laboratories Limited

DIVISLAB

Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract man...

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Divi, Kiran

Employees

9,741

IPO Date

2003-03-12

Headquarters

Divi Towers, 1-72/23(P)/DIVIS/303, Cyber Hills, Gachibowli, Hyderabad 500032, India

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

COMPANY

Pricing

Dashboard

About Us

Contact Us

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.